KEQU Kewaunee Scientific Corporation

  1. Stocks
  2. Consumer Cyclical
  3. NASDAQ: KEQU

Price (delayed)

$34.16

Market cap

$98.91M

P/E Ratio

11.94

Dividend/share

N/A

EPS

$2.86

Enterprise value

$144.12M

?
Relative Growth: Rel. Growth: 46
Relative Strength: Rel. Strength: 37
Relative Valuation: Rel. Valuation: 86
Relative Profitability: Rel. Profitability: 44

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's portfolio includes laboratory casework, ...

Highlights
Kewaunee Scientific's debt has decreased by 27% YoY and by 2.4% from the previous quarter
KEQU's equity is up by 12% YoY
KEQU's EPS is down by 33% year-on-year and by 15% since the previous quarter
The net income has declined by 33% year-on-year and by 14% since the previous quarter
Sector: Consumer Cyclical
Industry: Furnishings, Fixtures & Appliances
Website: http://www.kewaunee.com
Peers: SGI BSET LZB

Key stats

What are the main financial stats of KEQU

KEQU stock price

How has the Kewaunee Scientific stock price performed over time
Intraday
0.74%
1 week
0.41%
1 month
-5.92%
1 year
-21.13%
YTD
-8.69%
QTD
-0.84%

Financial performance

How have Kewaunee Scientific's revenue and profit performed over time
Revenue
$277.22M
Gross profit
$79.15M
Operating income
$15.06M
Net income
$8.23M
Gross margin
28.6%
Net margin
3%
Kewaunee Scientific's net margin has decreased by 36% YoY and by 12% from the previous quarter
The net income has declined by 33% year-on-year and by 14% since the previous quarter
The operating margin has decreased by 29% YoY and by 8% from the previous quarter
Kewaunee Scientific's operating income has decreased by 25% YoY and by 10% QoQ

Price vs fundamentals

How does KEQU's price correlate with its fundamentals

Growth

What is Kewaunee Scientific's growth rate over time

Valuation

What is Kewaunee Scientific stock price valuation
KEQU P/E details
P/E
11.94
P/B
1.31
P/S
0.35
EV/EBIT
9.68
EV/EBITDA
6.8
EV/Sales
0.52
KEQU's EPS is down by 33% year-on-year and by 15% since the previous quarter
KEQU's P/E is 8% above its last 4 quarters average of 11.0
KEQU's price to book (P/B) is 19% lower than its 5-year quarterly average of 1.6 and 13% lower than its last 4 quarters average of 1.5
KEQU's equity is up by 12% YoY
KEQU's price to sales (P/S) is 13% lower than its 5-year quarterly average of 0.4 and 13% lower than its last 4 quarters average of 0.4
The revenue rose by 5% year-on-year

Efficiency

How efficient is Kewaunee Scientific business performance
The ROE fell by 42% YoY and by 17% QoQ
Kewaunee Scientific's return on assets has decreased by 33% YoY and by 12% QoQ
KEQU's return on sales is down by 29% year-on-year and by 8% since the previous quarter
The ROIC has contracted by 25% YoY and by 8% from the previous quarter

Dividends

What is KEQU's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Kewaunee Scientific financials performed over time
Kewaunee Scientific's total assets is 78% more than its total liabilities
The total liabilities has decreased by 21% YoY and by 2.9% from the previous quarter
Kewaunee Scientific's total assets has decreased by 9% YoY
Kewaunee Scientific's debt is 26% less than its equity
KEQU's debt to equity is down by 35% year-on-year and by 2.6% since the previous quarter
Kewaunee Scientific's debt has decreased by 27% YoY and by 2.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.